Manentia’s Go-Live with BSI eClinical Solution Confirms the Successful SME Strategy Adopted by the Swiss Software House
BADEN, SWITZERLAND, March 15, 2022 – Finding the right eClinical provider can be difficult, especially for a young clinical research organization working with remote staff across two countries. Yet this was not the case for Manentia, a full-service CRO employing clinical research assistants (CRAs) in England and Northern Ireland. As their CEO and Consultant Statistician David Fleet explained, “As soon as we came across BSI Life Sciences, we knew we had found the perfect match for our company. In December 2021, we were urgently looking for a CTMS that would help us manage a large clinical trial starting at the beginning of this year. Besides checking all our boxes, BSI’s eClinical solution was pretty much the only one on the market that ensured go-live in as little as four weeks.”
BSI’s expertise in small and medium-sized enterprises also appears to have played a role in Manentia’s choice. “We knew BSI’s customers included several other CROs and start-ups in Europe and the US,” continued Mr. Fleet. “That gave us confidence, as we are an agile business made up of few core employees and independent consultants, with flat hierarchies. I personally wanted to make sure that everyone felt involved in the software onboarding process, especially the CRAs, who would eventually spend the most time working with the eClinical tool.”
Like other SME clients, Manentia opted for the standard BSI CTMS configuration with integrated eTMF based on the DIA TMF reference model. In addition, they had BSI add additional custom templates for monitoring visit reports and follow-up letters. “Being able to plan and manage site monitoring visits from start to finish in a single place is a huge relief and a great shift for our team,” commented Fiona McNulty, Clinical Research Consultant at Manentia. “This will save us time and improve efficiency overall,” she added.
For Community Manager Life Sciences at BSI, Jan Nielsen, Manentia’s go-live is another success worth celebrating. “With Manentia we’re further expanding our SME portfolio in England and Northern Ireland. I’m confident more customers in the UK will follow.” Mr. Nielsen also emphasized the good collaboration with the whole team at Manentia. “I’m happy we not only delivered on our promises, but also developed a strong professional relationship with all software end users on the client’s side.”
Founded in 2015, Manentia Ltd is a full-service CRO based in Salisbury, England, with extensive experience in both Pharma and MEDDEV studies. Specialist areas include stem cells, vaccines, diagnostic/biomarkers, hospital registries, ePRO/eCOA, sequential methods and population pharmacokinetics. Their motto, “Better Drugs Through Better Testing,” summarizes their mission to take clinical innovation to marketed products. Through its over seven years in business, Manentia has worked with major sponsors in the UK and internationally, providing strategic consultancy, clinical oversight including monitoring and patient recruitment, and data management and analysis.